Select company
- Ticker/CompanyMarket Cap.
No results found
Select metric
Pick a metric...
$ -0.36Free Cash Flow per Share
VS
Market
Sector
Industry
History
$ 1.9Close
$ 1.53 - $ 2.27 52-Week Range
Ticker Information
Ticker
APUSCompany Name
APIMEDS PHARMACEUTICALS US INCSector
HealthcareIndustry
Drug Manufacturers - Specialty & GenericExchange
NYSEMKTAPIMEDS PHARMACEUTICALS US INC - Free Cash Flow per Share Chart Analysis (TTM)
From
Zoom
1Y
3Y
5Y
10Y
APUS - FCFPS Historical data
| Date | Free Cash Flow | Free Cash Flow per Share | Share Factor | Weighted Average Shares |
|---|---|---|---|---|
| 6/30/2025 | $ -3.68M | $ -0.36 | 1 | 10.37M |
| 3/31/2025 | $ 0 | $ 0 | 1 | 7.9M |
| 12/31/2024 | $ -733.53K | $ -0.09 | 1 | 7.9M |
| 9/30/2024 | $ 0 | $ 0 | 1 | 7.9M |
| 6/30/2024 | $ 0 | $ 0 | 1 | 7.9M |
| 12/31/2023 | $ -627.79K | $ -0.14 | 1 | 4.6M |
Key Performance Insights, Last 5 Years
- APIMEDS PHARMACEUTICALS US INC's latest trailing twelve months (TTM) FCFPS stands at $ -0.14.
- Over the past 5 years, APIMEDS PHARMACEUTICALS US INC's average FCFPS has been $ -0.19.
- The median FCFPS for APIMEDS PHARMACEUTICALS US INC during this period was $ -0.14
- APIMEDS PHARMACEUTICALS US INC reached its highest FCFPS over the past 5 years at $ -0.09.
- The lowest FCFPS recorded by APIMEDS PHARMACEUTICALS US INC in the same timeframe $ -0.36
Similar metrics to Shares WA:
- Operating Cash Flow per Share - [Calculation] The amount of Operating Cash Flow attributed to each share, calculated as [NCFO] divided by the weighted average number of shares [SharesWA] after adjusting for [ShareFactor].
- Book Value per Share - [Calculation] The amount of equity attributed to each share, calculated as [Equity] divided by the weighted average number of shares [SharesWA] after adjusting for [ShareFactor].
- Sales per Share - [Calculation] The amount of revenue attributed to each share, calculated as [Revenue] divided by the weighted average number of shares [SharesWA] after adjusting for [ShareFactor].
- EBIT per Share - [Calculation] The amount of earnings before interest and taxes attributed to each share, calculated as [EBIT] divided by the weighted average number of shares [SharesWA] after adjusting for [ShareFactor].
- EBITDA per Share - [Calculation] The amount of earnings before interest, taxes, depreciation, and amortization attributed to each share, calculated as [EBITDA] divided by the weighted average number of shares [SharesWA] after adjusting for [ShareFactor].
Definition of Free Cash Flow per Share
[Calculation] The amount of Free Cash Flow attributed to each share, calculated as [FCF] divided by the weighted average number of shares [SharesWA] after adjusting for [ShareFactor].FCF / (Shares WA * Share Factor)
(=) FCFPS FCFPS for APIMEDS PHARMACEUTICALS US INC is calculated as follows: FCF [ $ -627.79K ] / (Shares WA [ 4.6M ] * Share Factor [ 1 ])
(=) FCFPS [ $ -0.14 ] APUS - Free Cash Flow per Share, Last 5 years
$ -0.36
Minimum
Jun 30, 2025
$ -0.09
Maximum
Dec 31, 2024
$ -0.19
Average
$ -0.14
Median
FCFPS Benchmark AnalysisMarket
The chart above depicts the distribution of FCFPS for companies in the Total Stock Market. The average FCFPS of the companies is $ 0.81 with a standard deviation of $ 2.83.
The following table provides additional summary stats:
FCFPS in the Market:
| filtered constituents | 3.76K |
|---|---|
| min | $ -7.96 |
| max | $ 8.9 |
| average | $ 0.81 |
| median | $ 0.3 |
| std | $ 2.83 |